The Mexican consensus on irritable bowel syndrome

Carmona-Sánchez, Ramón; Icaza-Chávez, M.E.; Bielsa-Fernández, M.V.; Gómez-Escudero, O.; Bosques-Padilla, Francisco; Coss‐Adame, Enrique; Esquivel-Ayanegui, F.; Flores-Rendón, Ángel Ricardo; González-Martínez, M.A.; Huerta-Iga, Francisco; López‐Colombo, Aurelio; Méndez-Gutiérrez, T.H.; Noble-Lugo, Alejandra; Rojas, J.R. Nogueira-de; Raña-Garibay, R.H.; Remes-Troche, José María; Roesch-Dietlen, F.; Schmulson, Max; Soto-Pérez, Julio César; Tamayo, J.L.; Uscanga, Luis; Valdovinos, Miguel A.; Valerio-Ureña, Joaquín; Zavala-Solares, M.R.

doi:10.1016/j.rgmxen.2016.01.004

Cited by 13 publications

(14 citation statements)

References 117 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These results are different to other studies, which demonstrate that young adults with IBS have a worse HRQL than older adults with this condition (17,18).…”

Section: Discussioncontrasting

confidence: 99%

“…Studies undertaken in the United States of America and Chile have demonstrated that young adults with IBS have a worse HRQL than older adults with this condition, with female patients the most affected (17,18). IBS has a great economic impact in terms of health and work, as its symptoms can interfere with social and work life, affecting the HRQL of sufferers (19,20), with even the families of IBS patients presenting higher levels of stress which are comparable to those of caregivers of people with dementia (21).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study

et al. 2017

View full text Add to dashboard Cite

Background: Evidence shows the negative impact of irritable bowel syndrome on the quality of life of patients who suffer from the condition as compared to the general population.Objective: The objective of this study was to determine the health-related quality of life in adults with irritable bowel syndrome who are receiving treatment at a specialist hospital.Material and methods: The study had a cross-sectional prospective design. The study included consecutive patients diagnosed with irritable bowel syndrome under the Rome III criteria and attending outpatient appointments. The SF-36 questionnaire was applied in its standard Spanish version and the results were compared with population reference scores in Mexico. Statistical analysis was performed with the Student's t test, analysis of variance and the Chi-squared test, considering a significance of 0.05%.Results: One hundred and fifty-four patients were included in the study, 137 (89%) women and 17 (11%) men, with an average age of 52.8 (SD 12.6). The constipation, diarrhea and mixed subtypes comprised 85 (55.2%), 27 (17.5%) and 42 (27.3%) patients, respectively. The quality of life of patients with irritable bowel syndrome vs the population reference scores in Mexico were 50 vs 79 for the physical health sub-scale and 59.1 vs 76.7 for the mental health sub-scale, respectively (p = 0.000). No significant difference was found in quality of life among the irritable bowel syndrome subtypes (p > 0.05).Conclusions: Health-related quality of life is lower in patients with irritable bowel syndrome in a population in the North East of Mexico compared to the data taken from a population reference study undertaken in the same country, enabling an inference in the female population and a cautious one from the results found in the small male sample studied. There was no significant difference found in the quality of life according to the clinical subtype of irritable bowel syndrome.

show abstract

“…These results are different to other studies, which demonstrate that young adults with IBS have a worse HRQL than older adults with this condition (17,18).…”

Section: Discussioncontrasting

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Among guidelines published in the past 5 years, some include a weak recommendation of moderate exercise as a lifestyle change for the treatment of IBS, supported by a low evidence [78][79][80][81][82][83][84] , while others do not include any reference either in favor or against [85][86][87] .…”

Section: Physical Exercise In Ibs Clinical Guidelinesmentioning

confidence: 99%

The role of physical exercise in the treatment of IBS

Rey¹

2020

NGL

View full text Add to dashboard Cite

“…6 In young adults, faecal calprotectin (FC) is often assessed to distinguish between IBS and IBD, but this approach is not usually recommended as the sole screening tool for people over 50 because of their higher risk of organic GID, including neoplasms. [7][8][9][10][11][12] The high prevalence of IBS and low incidence of organic GID in people over 50 have led to suggestions that diagnosing functional GIDs in people over 50 should be based on their medical history, and that the number of investigations, including FC testing, should be kept to a minimum. [7][8][9][10][11][12] Despite recommendations that functional GIDs be diagnosed and managed in primary care, large numbers of patients with probable functional GIDs are unnecessarily referred for further assessment, including colonoscopy.…”

mentioning

confidence: 99%

“…[7][8][9][10][11][12] The high prevalence of IBS and low incidence of organic GID in people over 50 have led to suggestions that diagnosing functional GIDs in people over 50 should be based on their medical history, and that the number of investigations, including FC testing, should be kept to a minimum. [7][8][9][10][11][12] Despite recommendations that functional GIDs be diagnosed and managed in primary care, large numbers of patients with probable functional GIDs are unnecessarily referred for further assessment, including colonoscopy. [13][14][15] Inflammation is the key characteristic that distinguishes organic from functional GIDs.…”

mentioning

confidence: 99%

Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis

Prince

Gardiner

et al. 2019

Medical Journal of Australia

View full text Add to dashboard Cite

Objectives To assess the clinical effectiveness of faecal calprotectin (FC) testing for distinguishing between organic gastrointestinal diseases (organic GID), such as inflammatory bowel disease (IBD), and functional gastrointestinal disorders (functional GIDs). Study design Studies that assessed the accuracy of FC testing for differentiating between IBD or organic GID and functional GIDs were reviewed. Articles published in English during January 1998 – June 2018 that compared diagnostic FC testing in primary care and outpatient hospital settings with a reference test and employed the standard enzyme‐linked immunosorbent FC assay method with a cut‐off of 50 or 100 μg/g faeces were included. Study quality was assessed with QUADAS‐2, an evidence‐based quality assessment tool for diagnostic accuracy studies. Data sources MEDLINE and EMBASE; reference lists of screened articles. Data synthesis Eighteen relevant studies were identified. For distinguishing patients with organic GID (including IBD) from those with functional GIDs (16 studies), the estimated sensitivity of FC testing was 81% (95% CI, 74–86%), the specificity 81% (95% CI, 71–88%); area under the curve (AUC) was 0.87. For distinguishing IBD from functional GIDs (ten studies), sensitivity was 88% (95% CI, 80–93%), specificity 72% (95% CI, 59–82%), and AUC 0.89. Assuming a population prevalence of organic GID of 1%, the positive predictive value was 4.2%, the negative predictive value 100%. The difference in sensitivity and specificity between FC testing cut‐offs of 50 μg/g and 100 μg/g faeces was not statistically significant (P = 0.77). Conclusions FC testing is clinically useful for distinguishing organic GID (including IBD) from functional GIDs, and its incorporation into clinical practice for evaluating patients with lower gastrointestinal symptoms could lead to fewer patients with functional GIDs undergoing colonoscopy, reducing costs for both patients and the health system. PROSPERO registration CRD4201810507.

show abstract

The Mexican consensus on irritable bowel syndrome

Cited by 13 publications

References 117 publications

Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study

Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study

The role of physical exercise in the treatment of IBS

Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta‐analysis

Contact Info

Product

Resources

About